Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02358213
Other study ID # RB 14.133 ETREINTE
Secondary ID
Status Completed
Phase N/A
First received January 26, 2015
Last updated December 15, 2015
Start date March 2015
Est. completion date March 2015

Study information

Verified date March 2015
Source University Hospital, Brest
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

This aim of this study is to compare the reproducibility of reading of five international experts concerning the anomalies of the salivary glands.

The reproducibility is measure on patients and not on recorded data.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date March 2015
Est. primary completion date March 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Men and women from 18 to 80 years old

- Patients recruited during the multidisciplinary consultation of Sjogren's Disease, filling the criteria of Sjogren's Disease or patients having a salivary recidivate pathology and selected players on the basis of their voluntary service to benefit from an ultrasound of the main salivary glands

- The patients will have to be capable of adhering to the protocol of study and of having understood it.

- The patients will have to be capable of giving a signed informed consent, the latter being obtained before the inclusion

Exclusion Criteria:

- Not cooperative patient and having refused to sign the informed consent.

- Patient incapable to understand the protocol, under guardianship or under guardianship.

- Unaffiliated patients to the Social Security.

Study Design

Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator)


Related Conditions & MeSH terms


Intervention

Procedure:
Ultrasound
Ultrasound examinations are done 5 times

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Brest

Outcome

Type Measure Description Time frame Safety issue
Primary Reproducibility between experts The outcome measure will be assessed bythe answer of a questionnaire which will be complete by the 5 international experts. 1 day No
Secondary Reproducibility by the sonographer The sonographer's reproductibility will be assesses by the answer of a questionnaire which will be complete by the 5 international experts. 1 day No
See also
  Status Clinical Trial Phase
Completed NCT02148497 - Multi-Colored Placido Disk Viability N/A
Completed NCT00740948 - Tolerance and Efficacy of Rituximab in Sjogren's Disease Phase 2/Phase 3
Not yet recruiting NCT06392711 - Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia Phase 1
Completed NCT01234623 - Cord Blood Serum in the Treatment of Ocular Surface Diseases Phase 1
Completed NCT02322528 - Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax N/A